APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phytopeptides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phytopeptides Industry Growth and Trends Forecast to 2032

24 December 2025111 pages

Choose your research edition.

Industry ResearchPhytopeptides Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Phytopeptides Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Phytopeptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phytopeptides Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Phytopeptides Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Phytopeptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phytopeptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phytopeptides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phytopeptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phytopeptides include Hubei Reborn Biotech, Phytocare, Ingredients To Die For, Fujian Dazhong Health Biotechnology, Theobroma Grandiflorum Seed Butter (and) Glycerin, Annzyme, Dezhou Lanli Biotechnology, Zhongshi Duqing (shandong) Biotech and Tallyho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phytopeptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phytopeptides market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phytopeptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phytopeptides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phytopeptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phytopeptides Market by Company

Hubei Reborn Biotech

Phytocare

Ingredients To Die For

Fujian Dazhong Health Biotechnology

Theobroma Grandiflorum Seed Butter (and) Glycerin

Annzyme

Dezhou Lanli Biotechnology

Zhongshi Duqing (shandong) Biotech

Tallyho

Biosynth

AmbioPharm

Aurobindo Pharma

Yasin Gelatin

Bachem

Creative Peptides

Shanghai Soho-Yiming Pharmaceuticals

Phytopeptides Segment by Type

Soy Peptides

Rice Peptides

Corn Peptides

Others

Phytopeptides Segment by Application

Health Food

Cosmetics

Others

Phytopeptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phytopeptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phytopeptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phytopeptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phytopeptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phytopeptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Soy Peptides Table 2. Major Company of Rice Peptides Table 3. Major Company of Corn Peptides Table 4. Major Company of Others Table 5. Global Phytopeptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Phytopeptides Sales by Type (2021-2026) & (Tons) Table 7. Global Phytopeptides Sales Market Share in Volume by Type (2021-2026) Table 8. Global Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 9. Global Phytopeptides Sales Market Share in Value by Type (2021-2026) Table 10. Global Phytopeptides Price by Type (2021-2026) & (US$/Ton) Table 11. Global Phytopeptides Sales by Type (2027-2032) & (Tons) Table 12. Global Phytopeptides Sales Market Share in Volume by Type (2027-2032) Table 13. Global Phytopeptides Sales by Type (2027-2032) & (US$ Million) Table 14. Global Phytopeptides Sales Market Share in Value by Type (2027-2032) Table 15. Global Phytopeptides Price by Type (2027-2032) & (US$/Ton) Table 16. North America Phytopeptides Sales by Type (2021-2026) & (Tons) Table 17. North America Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Phytopeptides Sales by Type (2021-2026) & (Tons) Table 19. Europe Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Phytopeptides Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Phytopeptides Sales by Type (2021-2026) & (Tons) Table 23. Latin America Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Phytopeptides Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Phytopeptides Sales by Type (2021-2026) & (US$ Million) Table 26. Phytopeptides Industry Trends Table 27. Phytopeptides Industry Drivers Table 28. Phytopeptides Industry Opportunities and Challenges Table 29. Phytopeptides Industry Restraints Table 30. Global Phytopeptides Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Phytopeptides Revenue Market Share by Company (2021-2026) Table 32. Global Phytopeptides Sales by Company (2021-2026) & (Tons) Table 33. Global Phytopeptides Sales Share by Company (2021-2026) Table 34. Global Phytopeptides Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Phytopeptides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Phytopeptides Major Company Production Sites and Headquarters Table 37. Global Phytopeptides Company, Product Type & Application Table 38. Global Phytopeptides Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Phytopeptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Phytopeptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Phytopeptides Sales by Region (2021-2026) & (Tons) Table 43. Global Phytopeptides Sales Market Share in Volume by Region (2021-2026) Table 44. Global Phytopeptides Sales by Region (2021-2026) & (US$ Million) Table 45. Global Phytopeptides Sales Market Share in Value by Region (2021-2026) Table 46. Global Phytopeptides Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Phytopeptides Sales by Region (2027-2032) & (Tons) Table 48. Global Phytopeptides Sales Market Share in Volume by Region (2027-2032) Table 49. Global Phytopeptides Sales by Region (2027-2032) & (US$ Million) Table 50. Global Phytopeptides Sales Market Share in Value by Region (2027-2032) Table 51. Global Phytopeptides Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Phytopeptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Phytopeptides Sales by Application (2021-2026) & (Tons) Table 54. Global Phytopeptides Sales Market Share in Volume by Application (2021-2026) Table 55. Global Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 56. Global Phytopeptides Sales Market Share in Value by Application (2021-2026) Table 57. Global Phytopeptides Price by Application (2021-2026) & (US$/Ton) Table 58. Global Phytopeptides Sales by Application (2027-2032) & (Tons) Table 59. Global Phytopeptides Sales Market Share in Volume by Application (2027-2032) Table 60. Global Phytopeptides Sales by Application (2027-2032) & (US$ Million) Table 61. Global Phytopeptides Sales Market Share in Value by Application (2027-2032) Table 62. Global Phytopeptides Price by Application (2027-2032) & (US$/Ton) Table 63. North America Phytopeptides Sales by Application (2021-2026) & (Tons) Table 64. North America Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Phytopeptides Sales by Application (2021-2026) & (Tons) Table 66. Europe Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Phytopeptides Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Phytopeptides Sales by Application (2021-2026) & (Tons) Table 70. Latin America Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Phytopeptides Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Phytopeptides Sales by Application (2021-2026) & (US$ Million) Table 73. Hubei Reborn Biotech Company Information Table 74. Hubei Reborn Biotech Business Overview Table 75. Hubei Reborn Biotech Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Hubei Reborn Biotech Phytopeptides Product Portfolio Table 77. Hubei Reborn Biotech Recent Development Table 78. Phytocare Company Information Table 79. Phytocare Business Overview Table 80. Phytocare Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Phytocare Phytopeptides Product Portfolio Table 82. Phytocare Recent Development Table 83. Ingredients To Die For Company Information Table 84. Ingredients To Die For Business Overview Table 85. Ingredients To Die For Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Ingredients To Die For Phytopeptides Product Portfolio Table 87. Ingredients To Die For Recent Development Table 88. Fujian Dazhong Health Biotechnology Company Information Table 89. Fujian Dazhong Health Biotechnology Business Overview Table 90. Fujian Dazhong Health Biotechnology Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Fujian Dazhong Health Biotechnology Phytopeptides Product Portfolio Table 92. Fujian Dazhong Health Biotechnology Recent Development Table 93. Theobroma Grandiflorum Seed Butter (and) Glycerin Company Information Table 94. Theobroma Grandiflorum Seed Butter (and) Glycerin Business Overview Table 95. Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Product Portfolio Table 97. Theobroma Grandiflorum Seed Butter (and) Glycerin Recent Development Table 98. Annzyme Company Information Table 99. Annzyme Business Overview Table 100. Annzyme Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Annzyme Phytopeptides Product Portfolio Table 102. Annzyme Recent Development Table 103. Dezhou Lanli Biotechnology Company Information Table 104. Dezhou Lanli Biotechnology Business Overview Table 105. Dezhou Lanli Biotechnology Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Dezhou Lanli Biotechnology Phytopeptides Product Portfolio Table 107. Dezhou Lanli Biotechnology Recent Development Table 108. Zhongshi Duqing (shandong) Biotech Company Information Table 109. Zhongshi Duqing (shandong) Biotech Business Overview Table 110. Zhongshi Duqing (shandong) Biotech Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Zhongshi Duqing (shandong) Biotech Phytopeptides Product Portfolio Table 112. Zhongshi Duqing (shandong) Biotech Recent Development Table 113. Tallyho Company Information Table 114. Tallyho Business Overview Table 115. Tallyho Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Tallyho Phytopeptides Product Portfolio Table 117. Tallyho Recent Development Table 118. Biosynth Company Information Table 119. Biosynth Business Overview Table 120. Biosynth Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Biosynth Phytopeptides Product Portfolio Table 122. Biosynth Recent Development Table 123. AmbioPharm Company Information Table 124. AmbioPharm Business Overview Table 125. AmbioPharm Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. AmbioPharm Phytopeptides Product Portfolio Table 127. AmbioPharm Recent Development Table 128. Aurobindo Pharma Company Information Table 129. Aurobindo Pharma Business Overview Table 130. Aurobindo Pharma Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Aurobindo Pharma Phytopeptides Product Portfolio Table 132. Aurobindo Pharma Recent Development Table 133. Yasin Gelatin Company Information Table 134. Yasin Gelatin Business Overview Table 135. Yasin Gelatin Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Yasin Gelatin Phytopeptides Product Portfolio Table 137. Yasin Gelatin Recent Development Table 138. Bachem Company Information Table 139. Bachem Business Overview Table 140. Bachem Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Bachem Phytopeptides Product Portfolio Table 142. Bachem Recent Development Table 143. Creative Peptides Company Information Table 144. Creative Peptides Business Overview Table 145. Creative Peptides Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Creative Peptides Phytopeptides Product Portfolio Table 147. Creative Peptides Recent Development Table 148. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 149. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 150. Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Product Portfolio Table 152. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 153. North America Phytopeptides Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 154. North America Phytopeptides Sales by Country (2021-2026) & (Tons) Table 155. North America Phytopeptides Sales Market Share by Country (2021-2026) Table 156. North America Phytopeptides Sales Forecast by Country (2027-2032) & (Tons) Table 157. North America Phytopeptides Sales Market Share Forecast by Country (2027-2032) Table 158. North America Phytopeptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Phytopeptides Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Phytopeptides Market Share by Country (2021-2026) Table 161. North America Phytopeptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Phytopeptides Market Share Forecast by Country (2027-2032) Table 163. Europe Phytopeptides Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 164. Europe Phytopeptides Sales by Country (2021-2026) & (Tons) Table 165. Europe Phytopeptides Sales Market Share by Country (2021-2026) Table 166. Europe Phytopeptides Sales Forecast by Country (2027-2032) & (Tons) Table 167. Europe Phytopeptides Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Phytopeptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Phytopeptides Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Phytopeptides Market Share by Country (2021-2026) Table 171. Europe Phytopeptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Phytopeptides Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Phytopeptides Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Phytopeptides Sales by Country (2021-2026) & (Tons) Table 175. Asia-Pacific Phytopeptides Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Phytopeptides Sales Forecast by Country (2027-2032) & (Tons) Table 177. Asia-Pacific Phytopeptides Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Phytopeptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Phytopeptides Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Phytopeptides Market Share by Country (2021-2026) Table 181. Asia-Pacific Phytopeptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Phytopeptides Market Share Forecast by Country (2027-2032) Table 183. Latin America Phytopeptides Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 184. Latin America Phytopeptides Sales by Country (2021-2026) & (Tons) Table 185. Latin America Phytopeptides Sales Market Share by Country (2021-2026) Table 186. Latin America Phytopeptides Sales Forecast by Country (2027-2032) & (Tons) Table 187. Latin America Phytopeptides Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Phytopeptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Phytopeptides Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Phytopeptides Market Share by Country (2021-2026) Table 191. Latin America Phytopeptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Phytopeptides Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Phytopeptides Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Phytopeptides Sales by Country (2021-2026) & (Tons) Table 195. Middle East and Africa Phytopeptides Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Phytopeptides Sales Forecast by Country (2027-2032) & (Tons) Table 197. Middle East and Africa Phytopeptides Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Phytopeptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Phytopeptides Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Phytopeptides Market Share by Country (2021-2026) Table 201. Middle East and Africa Phytopeptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Phytopeptides Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Phytopeptides Distributors List Table 206. Phytopeptides Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Phytopeptides Image Figure 2. Global Phytopeptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phytopeptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Phytopeptides Sales (2021-2032) & (Tons) Figure 5. Soy Peptides Image Figure 6. Global Soy Peptides Sales YoY Growth (2021-2032) & (Tons) Figure 7. Rice Peptides Image Figure 8. Global Rice Peptides Sales YoY Growth (2021-2032) & (Tons) Figure 9. Corn Peptides Image Figure 10. Global Corn Peptides Sales YoY Growth (2021-2032) & (Tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Phytopeptides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Phytopeptides Market Share by Type 2025 VS 2032 Figure 15. North America Phytopeptides Sales Market Share in Volume by Type in 2025 Figure 16. North America Phytopeptides Sales Market Share in Value by Type in 2025 Figure 17. Europe Phytopeptides Sales Market Share in Volume by Type in 2025 Figure 18. Europe Phytopeptides Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Phytopeptides Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Phytopeptides Sales Market Share in Value by Type in 2025 Figure 21. Latin America Phytopeptides Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Phytopeptides Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Phytopeptides Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Phytopeptides Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Phytopeptides Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Health Food Image Figure 28. Global Health Food Sales YoY Growth (2021-2032) & (Tons) Figure 29. Cosmetics Image Figure 30. Global Cosmetics Sales YoY Growth (2021-2032) & (Tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 33. Global Phytopeptides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Phytopeptides Market Share by Application 2025 VS 2032 Figure 35. North America Phytopeptides Sales Market Share in Volume by Application in 2025 Figure 36. North America Phytopeptides Sales Market Share in Value by Application in 2025 Figure 37. Europe Phytopeptides Sales Market Share in Volume by Application in 2025 Figure 38. Europe Phytopeptides Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Phytopeptides Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Phytopeptides Sales Market Share in Value by Application in 2025 Figure 41. Latin America Phytopeptides Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Phytopeptides Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Phytopeptides Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Phytopeptides Sales Market Share in Value by Application in 2025 Figure 45. North America Phytopeptides Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. North America Phytopeptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Phytopeptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Phytopeptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Phytopeptides Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Europe Phytopeptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Phytopeptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Phytopeptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Phytopeptides Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Asia-Pacific Phytopeptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Phytopeptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Phytopeptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Phytopeptides Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Latin America Phytopeptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Phytopeptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Phytopeptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Phytopeptides Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Middle East and Africa Phytopeptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Phytopeptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Phytopeptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Phytopeptides Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Phytopeptides Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Soy Peptides
  • Rice Peptides
  • Corn Peptides
  • Others
Applications
  • Health Food
  • Cosmetics
  • Others
Companies covered
  • Hubei Reborn Biotech
  • Phytocare
  • Ingredients To Die For
  • Fujian Dazhong Health Biotechnology
  • Theobroma Grandiflorum Seed Butter (and) Glycerin
  • Annzyme
  • Dezhou Lanli Biotechnology
  • Zhongshi Duqing (shandong) Biotech
  • Tallyho
  • Biosynth
  • AmbioPharm
  • Aurobindo Pharma
  • Yasin Gelatin
  • Bachem
  • Creative Peptides
  • Shanghai Soho-Yiming Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phytopeptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phytopeptides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phytopeptides Market by Type
  6. 1.3.1 Soy Peptides
  7. 1.3.2 Rice Peptides
  8. 1.3.3 Corn Peptides
  9. 1.3.4 Others
  10. 1.4 Global Phytopeptides Market Size by Type
  11. 1.4.1 Global Phytopeptides Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Phytopeptides Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Phytopeptides Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Phytopeptides Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Phytopeptides Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Phytopeptides Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Phytopeptides Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Phytopeptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phytopeptides Industry Trends
  2. 2.2 Phytopeptides Industry Drivers
  3. 2.3 Phytopeptides Industry Opportunities and Challenges
  4. 2.4 Phytopeptides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phytopeptides Revenue (2021-2026)
  2. 3.2 Global Top Players by Phytopeptides Sales (2021-2026)
  3. 3.3 Global Top Players by Phytopeptides Price (2021-2026)
  4. 3.4 Global Phytopeptides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phytopeptides Major Company Production Sites & Headquarters
  6. 3.6 Global Phytopeptides Company, Product Type & Application
  7. 3.7 Global Phytopeptides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phytopeptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phytopeptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phytopeptides Tier 1, Tier 2, and Tier 3
4 Phytopeptides Regional Status and Outlook
  1. 4.1 Global Phytopeptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phytopeptides Historic Market Size by Region
  3. 4.2.1 Global Phytopeptides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phytopeptides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phytopeptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phytopeptides Forecasted Market Size by Region
  7. 4.3.1 Global Phytopeptides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phytopeptides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phytopeptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phytopeptides by Application
  1. 5.1 Phytopeptides Market by Application
  2. 5.1.1 Health Food
  3. 5.1.2 Cosmetics
  4. 5.1.3 Others
  5. 5.2 Global Phytopeptides Market Size by Application
  6. 5.2.1 Global Phytopeptides Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Phytopeptides Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Phytopeptides Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Phytopeptides Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Phytopeptides Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Phytopeptides Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Phytopeptides Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Phytopeptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hubei Reborn Biotech
  2. 6.1.1 Hubei Reborn Biotech Company Information
  3. 6.1.2 Hubei Reborn Biotech Business Overview
  4. 6.1.3 Hubei Reborn Biotech Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hubei Reborn Biotech Phytopeptides Product Portfolio
  6. 6.1.5 Hubei Reborn Biotech Recent Developments
  7. 6.2 Phytocare
  8. 6.2.1 Phytocare Company Information
  9. 6.2.2 Phytocare Business Overview
  10. 6.2.3 Phytocare Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Phytocare Phytopeptides Product Portfolio
  12. 6.2.5 Phytocare Recent Developments
  13. 6.3 Ingredients To Die For
  14. 6.3.1 Ingredients To Die For Company Information
  15. 6.3.2 Ingredients To Die For Business Overview
  16. 6.3.3 Ingredients To Die For Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ingredients To Die For Phytopeptides Product Portfolio
  18. 6.3.5 Ingredients To Die For Recent Developments
  19. 6.4 Fujian Dazhong Health Biotechnology
  20. 6.4.1 Fujian Dazhong Health Biotechnology Company Information
  21. 6.4.2 Fujian Dazhong Health Biotechnology Business Overview
  22. 6.4.3 Fujian Dazhong Health Biotechnology Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fujian Dazhong Health Biotechnology Phytopeptides Product Portfolio
  24. 6.4.5 Fujian Dazhong Health Biotechnology Recent Developments
  25. 6.5 Theobroma Grandiflorum Seed Butter (and) Glycerin
  26. 6.5.1 Theobroma Grandiflorum Seed Butter (and) Glycerin Company Information
  27. 6.5.2 Theobroma Grandiflorum Seed Butter (and) Glycerin Business Overview
  28. 6.5.3 Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Product Portfolio
  30. 6.5.5 Theobroma Grandiflorum Seed Butter (and) Glycerin Recent Developments
  31. 6.6 Annzyme
  32. 6.6.1 Annzyme Company Information
  33. 6.6.2 Annzyme Business Overview
  34. 6.6.3 Annzyme Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Annzyme Phytopeptides Product Portfolio
  36. 6.6.5 Annzyme Recent Developments
  37. 6.7 Dezhou Lanli Biotechnology
  38. 6.7.1 Dezhou Lanli Biotechnology Company Information
  39. 6.7.2 Dezhou Lanli Biotechnology Business Overview
  40. 6.7.3 Dezhou Lanli Biotechnology Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dezhou Lanli Biotechnology Phytopeptides Product Portfolio
  42. 6.7.5 Dezhou Lanli Biotechnology Recent Developments
  43. 6.8 Zhongshi Duqing (shandong) Biotech
  44. 6.8.1 Zhongshi Duqing (shandong) Biotech Company Information
  45. 6.8.2 Zhongshi Duqing (shandong) Biotech Business Overview
  46. 6.8.3 Zhongshi Duqing (shandong) Biotech Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zhongshi Duqing (shandong) Biotech Phytopeptides Product Portfolio
  48. 6.8.5 Zhongshi Duqing (shandong) Biotech Recent Developments
  49. 6.9 Tallyho
  50. 6.9.1 Tallyho Company Information
  51. 6.9.2 Tallyho Business Overview
  52. 6.9.3 Tallyho Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tallyho Phytopeptides Product Portfolio
  54. 6.9.5 Tallyho Recent Developments
  55. 6.10 Biosynth
  56. 6.10.1 Biosynth Company Information
  57. 6.10.2 Biosynth Business Overview
  58. 6.10.3 Biosynth Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Biosynth Phytopeptides Product Portfolio
  60. 6.10.5 Biosynth Recent Developments
  61. 6.11 AmbioPharm
  62. 6.11.1 AmbioPharm Company Information
  63. 6.11.2 AmbioPharm Business Overview
  64. 6.11.3 AmbioPharm Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AmbioPharm Phytopeptides Product Portfolio
  66. 6.11.5 AmbioPharm Recent Developments
  67. 6.12 Aurobindo Pharma
  68. 6.12.1 Aurobindo Pharma Company Information
  69. 6.12.2 Aurobindo Pharma Business Overview
  70. 6.12.3 Aurobindo Pharma Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aurobindo Pharma Phytopeptides Product Portfolio
  72. 6.12.5 Aurobindo Pharma Recent Developments
  73. 6.13 Yasin Gelatin
  74. 6.13.1 Yasin Gelatin Company Information
  75. 6.13.2 Yasin Gelatin Business Overview
  76. 6.13.3 Yasin Gelatin Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yasin Gelatin Phytopeptides Product Portfolio
  78. 6.13.5 Yasin Gelatin Recent Developments
  79. 6.14 Bachem
  80. 6.14.1 Bachem Company Information
  81. 6.14.2 Bachem Business Overview
  82. 6.14.3 Bachem Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bachem Phytopeptides Product Portfolio
  84. 6.14.5 Bachem Recent Developments
  85. 6.15 Creative Peptides
  86. 6.15.1 Creative Peptides Company Information
  87. 6.15.2 Creative Peptides Business Overview
  88. 6.15.3 Creative Peptides Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Creative Peptides Phytopeptides Product Portfolio
  90. 6.15.5 Creative Peptides Recent Developments
  91. 6.16 Shanghai Soho-Yiming Pharmaceuticals
  92. 6.16.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  93. 6.16.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  94. 6.16.3 Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Product Portfolio
  96. 6.16.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Phytopeptides Sales by Country
  2. 7.1.1 North America Phytopeptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phytopeptides Sales by Country (2021-2026)
  4. 7.1.3 North America Phytopeptides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phytopeptides Market Size by Country
  6. 7.2.1 North America Phytopeptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phytopeptides Market Size by Country (2021-2026)
  8. 7.2.3 North America Phytopeptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phytopeptides Sales by Country
  2. 8.1.1 Europe Phytopeptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phytopeptides Sales by Country (2021-2026)
  4. 8.1.3 Europe Phytopeptides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phytopeptides Market Size by Country
  6. 8.2.1 Europe Phytopeptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phytopeptides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phytopeptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phytopeptides Sales by Country
  2. 9.1.1 Asia-Pacific Phytopeptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phytopeptides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phytopeptides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phytopeptides Market Size by Country
  6. 9.2.1 Asia-Pacific Phytopeptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phytopeptides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phytopeptides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phytopeptides Sales by Country
  2. 10.1.1 South America Phytopeptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phytopeptides Sales by Country (2021-2026)
  4. 10.1.3 South America Phytopeptides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phytopeptides Market Size by Country
  6. 10.2.1 South America Phytopeptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phytopeptides Market Size by Country (2021-2026)
  8. 10.2.3 South America Phytopeptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phytopeptides Sales by Country
  2. 11.1.1 Middle East and Africa Phytopeptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phytopeptides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phytopeptides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phytopeptides Market Size by Country
  6. 11.2.1 Middle East and Africa Phytopeptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phytopeptides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phytopeptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phytopeptides Value Chain Analysis
  2. 12.1.1 Phytopeptides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phytopeptides Production Mode & Process
  7. 12.2 Phytopeptides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phytopeptides Distributors
  10. 12.2.3 Phytopeptides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst